December 7, 2020 08:12 AM ESTUpdated 10:01 AM
Coronavirus

Covid-19 roundup: In­dia moves for­ward with re­view of Pfiz­er and As­traZeneca vac­cine can­di­dates; Chi­na's Sino­vac gets $515M to dou­ble vac­cine pro­duc­tion

Nicole DeFeudis

Editor

Less than a week af­ter Pfiz­er and BioN­Tech land­ed a his­toric au­tho­riza­tion for their Covid-19 vac­cine in the UK, In­dia is speed­ing up its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force in lat­est job cuts

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

SiteOne Ther­a­peu­tics, a pain biotech that's part­nered with Ver­tex, nabs $100M

In sur­prise move, FDA's No. 2 Bum­pus to leave agency at end of 2024

A service from the Financial Times